|
|
 |
Technological
Challenges
in Engineering a Retinal Implant
|
|
The
artificial retina consists of an electrode-studded soft
polymer array (shown) that is tacked to the retina inside
the eye. |
Researchers
face numerous challenges in developing retinal prosthetic devices
that are effective, safe, and durable enough to last for the lifetime
of the individual.
The retinal device
bypasses the eye's lost light-gathering function of the rods and
cones with a video camera. The information captured by the camera
is used to electrically stimulate the part of the retina not destroyed
by disease. Stimulation is done with a thin, flexible metal electrode
array that has been patterned on soft plastic material similar
to that of a contact lens.
The device must be
biocompatible with delicate eye tissue, yet tough enough to withstand
the corrosive effect of the salty environment. It should remain
stably tacked to the retinal macula and not overly compress or
pull at the tissue--the resilience of which can be compared to
that of a wet Kleenex®. The apparatus also needs to be powered
at a high enough level to stimulate the electrodes, yet not generate
enough heat to damage the remaining functional retinal cells.
|
| Increasing
Resolution. These images aproximate what patients with retinal
devices ideally could see. It is hoped that increasing the
number of electrodes will result in more visual perceptions
and higher-resolution vision. Click on photo for larger
image. [Credit: California Institute of Technology] |
Moreover,
just as the resolution of graphic images on a computer screen
improves with greater pixel density, researchers assume that increased
electrode densities will translate into higher-resolution images
for patients. However, the area of the retina targeted for electrical
stimulation is less than 5 mm by 5 mm. Consequently, as the number
of electrodes increases, their size and spacing must decrease.
Furthermore, image
processing needs to be performed in real time so there is no delay
in interpreting an object in view. Development of effective surgical
approaches is also critically important to ensure a successful
implant (see sidebar, Ensuring Surgical Reproducibility, below).
In other words, engineering
a retinal prosthesis is somewhat analogous to constructing a miniature
iPod® on a foldable contact lens that works in seawater.
| Ensuring
Surgical Reproducibility |
|
Designing
a robust, biocompatible retinal prosthesis is one thing.
However, another challenge lies in developing easily replicable
surgical techniques to place the implant in just the right
spot on the retinal macula and keep it there.
Many of the maneuvers surgeons perform during implantation
of the Argus™ II are standard techniques any experienced
retinal surgeon has used numerous times, says Mark Humayun,
a vitreoretinal surgeon and associate director of research
at the University of Southern California’s Doheny
Eye Institute. Introducing the electrode array into the
eye and tacking it to the retina are new tasks requiring
novel, advanced approaches not within a retinal surgeon’s
normal arsenal.
Consequently, “We tried to tailor the approach to
processes mimicking those that surgeons already follow,”
says Humayun, who pioneered the implantation procedure.
Another key to achieving surgical reproducibility is using
easy-to-handle materials whose look and feel are like those
with which surgeons already are comfortable. For example,
the telemetry coil is mounted on a scleral buckle, which
surgeons place around the eye for retinal detachments.
“We’ve really reduced this technique more to
science than art so that it can be more easily reproduced,”
Humayun says.
Although still a complex procedure, “It’s a
surgery that’s doable, and I think it’s very
reasonable that this will become a much more widely used
technique,” says Lyndon da Cruz, a vitreoretinal surgeon
at Moorfields Eye Hospital in London who is participating
in the Argus™ II clinical trials. “We feel we’re
part of something that’s genuinely new, innovative,
and cutting edge,” he adds. |
Promising Advances
Three devices of increasing resolution
are now in testing or development. Several pioneering technological
advances in fabrication and packaging by DOE national laboratories
(see Artificial Retina Team Garners
2009 R&D 100 Award) have helped make the third-generation
device a reality. For example, the significantly higher electrode
density required new lithographic and etching techniques to pattern
platinum films on soft polymer materials. Additionally, new stacking
techniques were needed to layer metals and polymers on top of
each other to achieve a narrower prosthesis in the section that
delivers electrical charges to the electrodes. Other advances
by DOE national laboratories include softening the rim of the
array that is in contact with delicate retinal neurons and improving
techniques to ensure none of the electrodes short-circuit.
Because the device’s
advanced electronics operate in the eye’s saltwater environment,
DOE’s national laboratories have spearheaded critical innovations
in packaging. These innovations include higher interconnect densities
of the individual contacts and attachment to the electronic chip
while still preserving a leak-tight electrical connection. A novel,
dual-sided integrated circuit also has been developed for stacking
components and interconnecting them (see Lab
Spotlight: Sandia National Laboratories). Research also is
under way on various bioadhesives that could be used to attach
the microelectrode array to the retinal surface.
|
| Fabricated
200+ thin-film electrode array. The metal traces
forming the electrodes in the artificial retina are less
than a micrometer thick—less than 1% the thickness
of a human hair.Click on photo for larger image. [Credit:
California Institute of Technology] |
Work in Progress
As the DOE Artificial Retina Project moves forward, prospects
for additional progress include developing a device with 1000
or more electrodes that can be scaled up using the knowledge gained
in creating the 200+ model. Various advances and spinoffs from
this work already are beginning to pay off in other biomedical
applications as well as in a wide range of hybrid surveillance
systems, including environmental sensors, and for plant and bacteria
studies (see story, Artificial Retina
Project Spurring Spinoff Technologies).
|